Associated Papers
CRISPR/Cas-Based Gene Editing Strategies for DOCK8 Immunodeficiency Syndrome.
Ravendran S et al.
Frontiers in Genome Editing, 2022
Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency.
Al-Zahrani D et al.
Clinical Immunology (orlando, Fla.), 2014
Select a paper to view details